Genome-wide association and epigenome-wide association studies have begun to offer new insights into patients with COVID-19 who are particularly prone to developing severe interstitial pneumonia [35,36,37], while exome and genome sequencing have helped identify a rare variant of TLR7 that may lead to severe COVID-19 outcomes [38]. This evidence concerns the gene TLR7 and COVID-19.